GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile
Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease
Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer
CMX001 Reduces Adenovirus Progression and Viremia
Biomarker Identified Predicting Graft-Versus-Host Disease Risk
Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan
Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival
Pretreatment with Azacitidine Achieves 28-Month Remission
Specific Pathology Pattern Can Predict Recurrence
20% of Women Do Not Believe Tailored Risk Assessments
Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer
Study Finds Gene Expression Test Predicts Stage I or II Recurrence
NCI CTEP Approved Trials For the Month of August
FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma
Trending Stories
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- How George Tidmarsh crossed the FDA-industry Rubicon
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
